K. Amande M. Pauls
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
K. Amande M. Pauls has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Elena Moro
Division of Neurology, University Hospital Center of Grenoble, Grenoble, France
2 shared publicationsFaycal El Majdoub
Department of Stereotaxic and Functional Neurosurgery, Uniklinik Köln, Cologne, Germany
2 shared publications- Gereon Rudolph Fink
Department of Neurology, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany
2 shared publications Joachim K. Krauss
Department of Neurosurgery, Medizinische Hochschule Hannover, Hannover, Germany
2 shared publicationsLars Timmermann
Department of Neurology, Uniklinik Köln, Cologne, Germany
2 shared publications- Lars Timmermann
Klinik für Neurologie, Universitätsklinikum Giessen und Marburg, Standort Marburg, Marburg, Deutschland
2 shared publications
Latest Publications
- Open Access
- 1 February 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 47, 71-75
Dysarthria in pallidal Deep Brain Stimulation in dystonia depends on the posterior location of active electrode contacts: a pilot study
- 1 February 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 47, 71-75
Open AccessDysarthria in pallidal Deep Brain Stimulation in dystonia depends on the posterior location of active electrode contacts: a pilot study
- Open Access
- 1 October 2017
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 43, 38-48
Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia
- 1 October 2017
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 43, 38-48
Open AccessCauses of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia
- 21 April 2014
- Published by Wiley in Movement Disorders
- Vol. 29 (7) , 953-959
Deep brain stimulation in the ventrolateral thalamus/subthalamic area in dystonia with head tremor
Background: Pallidal deep brain stimulation (GPi‐DBS) effectively ameliorates idiopathic dystonia, although approximately 15% of patients respond insufficiently. Although various thalamic and subthalamic targets have been suggested for dystonic tremor, no systematic studies have been published on thalamic DBS in dystonic tremor. We assessed the effect of thalamic/subthalamic area DBS (Th‐DBS) on dystonic head tremor and dystonia in a single‐blind design.Methods: Dystonic head tremor and dystonia before and 3 months after surgery were quantified via blinded video‐ratings using the Fahn‐Tolosa‐Marin‐Tremor‐Scale and the Burke‐Fahn‐Marsden‐Dystonia‐Rating‐Scale in seven patients with idiopathic cervical or segmental dystonia, dystonic head tremor, and bilateral Th‐DBS. Pain, side effects, adverse events, and stimulation parameters were assessed.Results: Th‐DBS improved dystonic tremor and dystonia (P < 0.05; 57.1% and 70.4%, respectively). Head tremor amplitude and pain were also improved (P < 0.05; 77.5% and 90.0%, respectively). Side effects included dysarthria, gait disturbance, slowness of movement, and weight gain.Conclusion: Dystonic head tremor and dystonia can be improved with Th‐DBS. © 2014 International Parkinson and Movement Disorder Society
- 21 April 2014
- Published by Wiley in Movement Disorders
- Vol. 29 (7) , 953-959
Deep brain stimulation in the ventrolateral thalamus/subthalamic area in dystonia with head tremor
Background: Pallidal deep brain stimulation (GPi‐DBS) effectively ameliorates idiopathic dystonia, although approximately 15% of patients respond insufficiently. Although various thalamic and subthalamic targets have been suggested for dystonic tremor, no systematic studies have been published on thalamic DBS in dystonic tremor. We assessed the effect of thalamic/subthalamic area DBS (Th‐DBS) on dystonic head tremor and dystonia in a single‐blind design.Methods: Dystonic head tremor and dystonia before and 3 months after surgery were quantified via blinded video‐ratings using the Fahn‐Tolosa‐Marin‐Tremor‐Scale and the Burke‐Fahn‐Marsden‐Dystonia‐Rating‐Scale in seven patients with idiopathic cervical or segmental dystonia, dystonic head tremor, and bilateral Th‐DBS. Pain, side effects, adverse events, and stimulation parameters were assessed.Results: Th‐DBS improved dystonic tremor and dystonia (P < 0.05; 57.1% and 70.4%, respectively). Head tremor amplitude and pain were also improved (P < 0.05; 77.5% and 90.0%, respectively). Side effects included dysarthria, gait disturbance, slowness of movement, and weight gain.Conclusion: Dystonic head tremor and dystonia can be improved with Th‐DBS. © 2014 International Parkinson and Movement Disorder Society
- 1 April 2014
- Published by Elsevier in Experimental Neurology
- Vol. 254, 70-77
Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease
- 1 April 2014
- Published by Elsevier in Experimental Neurology
- Vol. 254, 70-77
Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease
- Open Access
- 5 March 2010
- Published by Oxford University Press (OUP) in Brain
- Vol. 133 (3) , 701-712
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation
Neurodegeneration with brain iron accumulation encompasses a heterogeneous group of rare neurodegenerative disorders that are characterized by iron accumulation in the brain. Severe generalized dystonia is frequently a prominent symptom and can be very disabling, causing gait impairment, difficulty with speech and swallowing, pain and respiratory distress. Several case reports and one case series have been published concerning therapeutic outcome of pallidal deep brain stimulation in dystonia caused by neurodegeneration with brain iron degeneration, reporting mostly favourable outcomes. However, with case studies, there may be a reporting bias towards favourable outcome. Thus, we undertook this multi-centre retrospective study to gather worldwide experiences with bilateral pallidal deep brain stimulation in patients with neurodegeneration with brain iron accumulation. A total of 16 centres contributed 23 patients with confirmed neurodegeneration with brain iron accumulation and bilateral pallidal deep brain stimulation. Patient details including gender, age at onset, age at operation, genetic status, magnetic resonance imaging status, history and clinical findings were requested. Data on severity of dystonia (Burke Fahn Marsden Dystonia Rating Scale—Motor Scale, Barry Albright Dystonia Scale), disability (Burke Fahn Marsden Dystonia Rating Scale—Disability Scale), quality of life (subjective global rating from 1 to 10 obtained retrospectively from patient and caregiver) as well as data on supportive therapy, concurrent pharmacotherapy, stimulation settings, adverse events and side effects were collected. Data were collected once preoperatively and at 2–6 and 9–15 months postoperatively. The primary outcome measure was change in severity of dystonia. The mean improvement in severity of dystonia was 28.5% at 2–6 months and 25.7% at 9–15 months. At 9–15 months postoperatively, 66.7% of patients showed an improvement of 20% or more in severity of dystonia, and 31.3% showed an improvement of 20% or more in disability. Global quality of life ratings showed a median improvement of 83.3% at 9–15 months. Severity of dystonia preoperatively and disease duration predicted improvement in severity of dystonia at 2–6 months; this failed to reach significance at 9–15 months. The study confirms that dystonia in neurodegeneration with brain iron accumulation improves with bilateral pallidal deep brain stimulation, although this improvement is not as great as the benefit reported in patients with primary generalized dystonias or some other secondary dystonias. The patients with more severe dystonia seem to benefit more. A well-controlled, multi-centre prospective study is necessary to enable evidence-based therapeutic decisions and better predict therapeutic outcomes.
- 5 March 2010
- Published by Oxford University Press (OUP) in Brain
- Vol. 133 (3) , 701-712
Open AccessDystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation
Neurodegeneration with brain iron accumulation encompasses a heterogeneous group of rare neurodegenerative disorders that are characterized by iron accumulation in the brain. Severe generalized dystonia is frequently a prominent symptom and can be very disabling, causing gait impairment, difficulty with speech and swallowing, pain and respiratory distress. Several case reports and one case series have been published concerning therapeutic outcome of pallidal deep brain stimulation in dystonia caused by neurodegeneration with brain iron degeneration, reporting mostly favourable outcomes. However, with case studies, there may be a reporting bias towards favourable outcome. Thus, we undertook this multi-centre retrospective study to gather worldwide experiences with bilateral pallidal deep brain stimulation in patients with neurodegeneration with brain iron accumulation. A total of 16 centres contributed 23 patients with confirmed neurodegeneration with brain iron accumulation and bilateral pallidal deep brain stimulation. Patient details including gender, age at onset, age at operation, genetic status, magnetic resonance imaging status, history and clinical findings were requested. Data on severity of dystonia (Burke Fahn Marsden Dystonia Rating Scale—Motor Scale, Barry Albright Dystonia Scale), disability (Burke Fahn Marsden Dystonia Rating Scale—Disability Scale), quality of life (subjective global rating from 1 to 10 obtained retrospectively from patient and caregiver) as well as data on supportive therapy, concurrent pharmacotherapy, stimulation settings, adverse events and side effects were collected. Data were collected once preoperatively and at 2–6 and 9–15 months postoperatively. The primary outcome measure was change in severity of dystonia. The mean improvement in severity of dystonia was 28.5% at 2–6 months and 25.7% at 9–15 months. At 9–15 months postoperatively, 66.7% of patients showed an improvement of 20% or more in severity of dystonia, and 31.3% showed an improvement of 20% or more in disability. Global quality of life ratings showed a median improvement of 83.3% at 9–15 months. Severity of dystonia preoperatively and disease duration predicted improvement in severity of dystonia at 2–6 months; this failed to reach significance at 9–15 months. The study confirms that dystonia in neurodegeneration with brain iron accumulation improves with bilateral pallidal deep brain stimulation, although this improvement is not as great as the benefit reported in patients with primary generalized dystonias or some other secondary dystonias. The patients with more severe dystonia seem to benefit more. A well-controlled, multi-centre prospective study is necessary to enable evidence-based therapeutic decisions and better predict therapeutic outcomes.